| CAV (n = 17) | No CAV (n = 17) | Old donor (n = 32) | Young donor (n = 32) | |
| Age, years (mean ± SD) | 55.6 ± 14 | 56.2 ± 14 | 57.5 ± 13.6 | 58.3 ± 12.9 |
| Male sex, no (%) of patients | 16 (94) | 16 (94) | 31 (97) | 31 (97) |
| Aetiology IHD, no (%) of patients | 10 (59) | 10 (59) | 21 (66.7) | 21 (66.7) |
| Aetiology cardiomyopathy, no (%) of patients | 7 (41) | 7 (41) | 11 (33.3) | 11 (33.3) |
| Time since transplantation, years (mean ± SD) | 11.5 ± 3.8 | 10.4 ± 3.6 | 9.7 ± 4.7 | 9.4 ± 4.4 |
| Systolic blood pressure, mm Hg (mean ± SD) | 132.9 ± 9.8 | 122.5 ± 35.6 | 132.4 ± 16.3 | 128.9 ± 12.5 |
| Serum creatinine, μmol/l (mean ± SD) | 148.1 ± 30 | 139.8 ± 50 | 155.7 ± 48.1 | 149.3 ± 10.4 |
| Serum cholesterol, mmol/l (mean ± SD) | 5 ± 1.2 | 4.9 ± 1.8 | 4.7 ± 0.9 | 4.9 ± 1.1 |
| Lymphocyte count, ×109 | 2.1 ± 1 | 1.7 ± 0.7 | 2.2 ± 0.9 | 1.8 ± 0.9 |
CAV, cardiac allograft vasculopathy; IHD, ischaemic heart disease.